Background There is no data regarding COVID-19 in Multiple Sclerosis (MS) and neuromyelitis
optica spectrum disorder (NMOSD) patients in Latin America. Objective The objective of …

One of the biggest challenges in multiple sclerosis (MS) is the definition of treatment
response/failure in order to optimize treatment decisions in affected patients. The objective of this …

Despite that different registries already exist in various countries in Europe and North
America, no ongoing nationwide registry exists in Latin America (LATAM), a region where the …

Background: Neuromyelitis optica spectrum disorder (NMOSD) misdiagnosis (ie the incorrect
diagnosis of patients who truly have NMOSD) remains an issue in clinical practice. We …

Background: Memory dysfunction is common in multiple sclerosis (MS). A retrieval failure
has been reported as the primary cause for the memory deficits, although some studies also …

Background Multiple sclerosis (MS) is the most common chronic immune-mediated
neurological disorder in young adults, more frequently found in women than in men. Therefore, …

Background Myelin oligodendrocyte glycoprotein antibodies (MOG-ab) have been described
in aquaporin-4-antibodies(AQP4-ab)-negative neuromyelitis optica spectrum disorder (…

The objective of this study was to describe and compare the baseline epidemiological data
of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients …

We aimed to evaluate mortality and causes of death among Argentinean neuromyelitis optica
spectrum disorder (NMOSD) patients and identify predictors of death. Retrospective study …

Background: We aimed to assess the frequency of new asymptomatic lesions on brain and
spinal imaging (magnetic resonance imaging (MRI)) and their association with subsequent …